![Michael M. Mueller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Michael M. Mueller
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael M. Mueller via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Leidos, Inc.
![]() Leidos, Inc. Information Technology ServicesTechnology Services Leidos, Inc. provides scientific, engineering, systems integration and technical services and solutions. It offers solutions and services that leverage the power of data analytics, systems integration, and cyber security across national security, health, and engineering markets. The company was founded by John Robert Beyster in June 1969 and is headquartered in Reston, VA. | Information Technology Services | Corporate Officer/Principal | |
XOMA CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Europe SA | Corporate Officer/Principal | ||
ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
Yale University | College/University | Doctorate Degree | |
University of Toronto | College/University | Doctorate Degree | |
Baruch College | College/University | Masters Business Admin | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ain Shams University | College/University | Graduate Degree | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
MOLECULAR PARTNERS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Corporate Officer/Principal | |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
Università degli Studi di Modena e Reggio Emilia | College/University | Doctorate Degree | |
Tibotec Pharmaceuticals | Chief Executive Officer | ||
USC Marshall School of Business | College/University | Masters Business Admin | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Acerta Pharma BV
![]() Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Executive Officer | |
Yale School of Medicine | College/University | Corporate Officer/Principal | |
Keck School of Medicine of USC
![]() Keck School of Medicine of USC Other Consumer ServicesConsumer Services The Keck School of Medicine of USC is a place of dynamic activity in patient care, scientific discovery, medical and bioscience education, and community service. Their faculty, staff, students, residents, alumni, donors and friends are committed to excellence. Together they are poised to lead medicine in the 21st Century for the benefit of humankind. This is an exciting time of great transformation as they endeavor to create a truly stellar academic medical center at USC. | College/University | Graduate Degree | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
X-Vax Technology, Inc.
![]() X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
ILKOS THERAPEUTICS, Inc.
![]() ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
![]() Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
OMEGA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Pomerantz Life Sciences Consulting Group LLC | President | ||
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Kartos Therapeutics, Inc.
![]() Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member | |
Sporos Bioventures, Inc.
![]() Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer | |
INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
![]() Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
Aprinoia Therapeutics, Inc. /US/
![]() Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Silicon Therapeutics, Inc. | Chairman | ||
Sermonix Pharmaceuticals LLC
![]() Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 35 |
Suisse | 4 |
Israël | 4 |
Belgique | 3 |
Canada | 3 |
Sectorielle
Health Technology | 31 |
Consumer Services | 11 |
Health Services | 3 |
Finance | 3 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 58 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 24 |
Chief Tech/Sci/R&D Officer | 14 |
Chairman | 13 |
Relations les plus connectées
Insiders | |
---|---|
Roger Pomerantz | 30 |
Nicole Onetto | 17 |
Gur Roshwalb | 17 |
Barry Simon | 15 |
Jane Barlow | 15 |
Thomas Darcy | 13 |
Lisa Rojkjaer | 12 |
Stephen Rubino | 10 |
Flavia Borellini | 9 |
Ayman El-Guindy | 4 |
Patric Nelson | 4 |
Ashleigh Barreto | 3 |
Biljana Nadjsombati | 2 |
- Bourse
- Insiders
- Michael M. Mueller
- Connexions Sociétés